161 related articles for article (PubMed ID: 7933089)
1. The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.
Demeret C; Yaniv M; Thierry F
J Virol; 1994 Nov; 68(11):7075-82. PubMed ID: 7933089
[TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
Tan SH; Leong LE; Walker PA; Bernard HU
J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
[TBL] [Abstract][Full Text] [Related]
3. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.
Demeret C; Desaintes C; Yaniv M; Thierry F
J Virol; 1997 Dec; 71(12):9343-9. PubMed ID: 9371593
[TBL] [Abstract][Full Text] [Related]
4. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
7. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.
Gloss B; Bernard HU
J Virol; 1990 Nov; 64(11):5577-84. PubMed ID: 2170687
[TBL] [Abstract][Full Text] [Related]
8. The hinge region of the human papillomavirus type 8 E2 protein activates the human p21(WAF1/CIP1) promoter via interaction with Sp1.
Steger G; Schnabel C; Schmidt HM
J Gen Virol; 2002 Mar; 83(Pt 3):503-510. PubMed ID: 11842244
[TBL] [Abstract][Full Text] [Related]
9. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
10. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
11. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
Dong XP; Pfister H
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
Oh ST; Kyo S; Laimins LA
J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
Steger G; Corbach S
J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
[TBL] [Abstract][Full Text] [Related]
14. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.
Nishimura A; Ono T; Ishimoto A; Dowhanick JJ; Frizzell MA; Howley PM; Sakai H
J Virol; 2000 Apr; 74(8):3752-60. PubMed ID: 10729150
[TBL] [Abstract][Full Text] [Related]
17. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.
Stubenrauch F; Leigh IM; Pfister H
J Virol; 1996 Jan; 70(1):119-26. PubMed ID: 8523515
[TBL] [Abstract][Full Text] [Related]
18. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence.
Peralta-Zaragoza O; Bermúdez-Morales V; Gutiérrez-Xicotencatl L; Alcocer-González J; Recillas-Targa F; Madrid-Marina V
Viral Immunol; 2006; 19(3):468-80. PubMed ID: 16987065
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.
Romanczuk H; Thierry F; Howley PM
J Virol; 1990 Jun; 64(6):2849-59. PubMed ID: 2159546
[TBL] [Abstract][Full Text] [Related]
20. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]